WILMINGTON, Del.--(BUSINESS WIRE)-- Incyte Corporation (Nasdaq: INCY) announced that it has scheduled a webcast for 8:00 p.m. ET today, Wednesday, November 10, 2010 to review the INCB28050 Phase II results being presented today at 5:30 p.m. ET during the 2010 ACR/ARHP Annual Scientific Meeting in Atlanta.
The live webcast can be accessed by going to our website at www.incyte.com under Investor Relations, Events and Webcasts. A replay of the webcast will also be available following the event.
About Incyte
Incyte Corporation is a Wilmington, Delaware-based drug discovery and development company focused on developing proprietary small molecule drugs for oncology and inflammation. For additional information on Incyte, visit the Company's web site at www.incyte.com.
CONTACT:
Incyte Corporation
Pamela M. Murphy
Vice President, Investor Relations & Corporate Communications
302-498-6944
KEYWORDS: United States North America Delaware Georgia
INDUSTRY KEYWORDS: Health Biotechnology Clinical Trials Oncology Pharmaceutical
MEDIA:
| Logo |